Epigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• DNA methylation is implicated in cancer development, but its role in early colorectal cancer (CRC) stages is unclear.
• Understanding epigenetic alterations driving CRC evolution is crucial for early detection and treatment.

Purpose of the Study:

• To identify novel genes epigenetically silenced in early CRC.
• To elucidate the functional role of α-internexin (INA) in colorectal tumorigenesis.

Main Methods:

• Genome-wide methylation screening to identify aberrant genes in colon adenoma and adenocarcinoma.
• Analysis of INA expression, methylation status, and its correlation with clinical outcomes.
• In vitro and in vivo studies to assess the functional impact of INA on cancer cell behavior and metastasis.
• Biochemical assays to determine the mechanism of INA's interaction with microtubules.

Main Results:

• Aberrant hypermethylation of the INA gene promoter was identified in CRC tissues.
• INA hypermethylation correlated with larger tumor size and predicted poor patient survival.
• Silencing of INA expression promoted cell proliferation, migration, and invasion.
• Restoring INA expression inhibited cancer cell migration, invasion, and reduced lung metastasis.
• INA directly inhibited microtubule polymerization via a tubulin-binding motif.

Conclusions:

• Epigenetic inactivation of INA is an early event in colorectal cancer progression.
• INA acts as a tumor suppressor by impeding microtubule polymerization.
• INA inactivation facilitates CRC development by promoting microtubule dynamics and cell motility.